Needle Array Drug Delivery Systems

Devices, Therapeutic Markets, Strategies and Prospects

Report Prospectus

Greystone Research
associates

Microneedle Drug Delivery: Technology, Devices, Markets, Players & Prospects

Greystone Research Associates is pleased to announce the publication of a new market study. Needle Array Drug Delivery Systems: Devices, Therapeutic Markets, Strategies and Prospects is a comprehensive evaluation and analysis of the technology, devices, product development strategies and participants that comprise the needle array segment of the medical device sector.

Needle Array Drug Delivery Systems

The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, healthcare segments and commercial opportunities for needle arrays and devices in the delivery of therapeutic drugs. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Evolving Materials Technology and Minimally Invasive Therapeutics Evolution in drug delivery device design is changing the way a growing number of therapeutic substances are administered. This trend is being fostered by the desire by patients for more user friendly methods for self-medicating, and by the need for safer, more reliable drug products that improve compliance. For drugs designed to be delivered across the skin, needle arrays are viewed as an approach that addresses these key healthcare objectives. Needle arrays offer several advantages when compared to conventional needle technologies including being minimally invasive due to their small cross-sectional area, providing precise penetration depth under the skin, inducing minimal trauma during insertion due to the advanced tip designs, and increased functionality. Important needle array fabrication technologies include micromachining, microforming, LIGA, and structured films. Prominent needle array form factors include solid (coated and uncoated) needle arrays, hollow needle arrays, dissolving needle arrays, programmable needle arrays, and phase transition needle arrays. Needle array technology is attaining commercial viability at a time when drug developers are faced with new challenges as they assess ways to administer a new class of compounds with significant therapeutic potential. The widespread availability of rapid throughput screening is accelerating the discovery of large-molecule therapeutic compounds that cannot tolerate passage through the digestive system, requiring pharmaceutical companies to forego oral formulations and select alternate routes of administration.

Table of Contents
Executive Summary Active Transdermal Delivery Market Dynamics
Drug Classes, Indications and Demand The Needle Array Ecosystem Whats Driving the Growth in Alternative Drug Delivery? Competitive Landscape Risk Factors

Needle Array Architecture, Technology & Fabrication

Needle Array Design Strategies Solid Needle Arrays Hollow Needle Arrays Coated Needle Arrays Dissolvable Needle Arrays Needle Array Geometries &Form Factors Needle Array Manufacturing Material Selection Issues Fabrication Techniques Emerging Fabrication Methods

Needle Array Drug Delivery Systems

Needle Array Delivery Systems Assessments & Commercial Prospects

Syringe-mounted Arrays Micronjet Nanoject Solid Needle Arrays sMTS Macroflux MicroCor Micropatch OnVax Unbranded (Nanomed) Hollow Needle Arrays hMTS Micro-Trans Unbranded (MyLife Technologies) Dissolvable Arrays VaxMAT Unbranded (BioSerenTach) Metal Film Needle Arrays AdminPatch Phase Transition Needle Array Patches Unbranded (BioPharm Solutions) Programmable Needle Array Patch Pyraderm Unbranded (Janisys) Spring Powered Needle Arrays Unbranded (PKA SoftTouch) Customizable Needle Arrays Unbranded (Micropoint Technologies)

Near-Terms Markets for Needle Arrays - Assessments & Forecasts

Dermatology/Cosmetic Surgery Diabetes Genetic/DNA/Nucleotide Therapeutics Oncology Osteoporosis Reproductive Medicine Vaccines

Market Factors
Regulatory Considerations Patient Preferences and Compliance Managed Care Initiatives

Company Profiles

Feature Summary
Provides assessments of marketed and development stage needle array drug delivery systems Analyzes and evaluates needle array technology and product research & development activities, and assesses the medical market potential for existing and probable future products Analyzes proprietary technologies and market development issues Provides detailed descriptions of medical needle array drug delivery business opportunities, market demographics, and business strategies Provides market data and forecasts to 2016 Profiles needle array product and technology participants, their activities, business strategies, and corporate alliances and affiliations Evaluates the impact of economic, technology, and regulatory factors on the commercial potential of microneedle systems

Needle Array Drug Delivery Systems

Report Format and Availability

This report is available in electronic format. A site license for a single physical location and an Enterprise license are also available. Custom licensing options to address specific company user requirements are available by calling client services at 603-595-4340, or by emailing clientservices@greystoneassociates.org. Methodology

Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations. Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations. Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques. About Greystone Research Associates

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

How To Order
Ordering Information
Orders may be placed via postal mail, e-mail or fax. Orders not accompanied by a purchase order must contain a telephone number for verification, and clearly indicate the physical shipping address. Orders which are not prepaid must indicate the billing address. There is no charge for handling and shipping for destination addresses within the continental US.

Payment
We accept the following forms of payment: Company Check: Please make checks payable to Greystone Associates Credit Cards: We accept MasterCard, Visa and American Express Wire Transfers: See Wire Transfers below for more information Orders Outside the U.S. Orders must be prepaid via credit card, company check in US funds and drawn on a US bank, or wire transfer. There is a $50 per copy shipping and handling charge for international shipments.

Wire Transfers:

TD Banknorth 300 Franklin Street Manchester, NH 03103 (Call for Account Information)

Mailing Address:

Greystone Research Associates Client Services P.O. Box 1362 Amherst, NH 03031

Needle Array Drug Delivery Systems

Select Format Price (U.S. funds) Total

Electronic Site License Enterprise License

$2,850.00 $4,500.00 $6,500.00

Total Payment (U.S. funds)

Method of Payment: ___ Company Check

___

___

___

___ Wire Transfer

(International)

Card Number:___________________________ Name on Card ________________________________________ Expiration Date: ____________ Card CVV_______ Signature___________________________________
Billing Information
Name: Title: Company: Street Address: City,State/Province: Country/Postal Code: Phone: Fax: Email:

Shipping Information Click here if same as Billing Information

Name: Title: Company: Street Address: City,State/Province: Country/Postal Code: Phone: Fax: Email:

98 Route 101A

P .O. Box 1362

Amherst, NH 03031

603-595-4340

(F) 603-218-7020 reports@greystoneassociates.org